Article Details
Retrieved on: 2024-02-08 20:56:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Meanwhile, BioNTech will gain access to Autolus's cell therapy manufacturing assets as well as technologies that could support the R&D of in vivo ...
Article found on: medcitynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here